Mindfulness-Based Postpartum Discharge Education on Maternal Role and Anxiety

July 9, 2026 updated by: Damlagül ACAR, Tokat Gaziosmanpasa University

The Effects of Mindfulness-Based Postpartum Discharge Education on Mothers' Maternal Role Perception and Anxiety Levels

This study will be conducted as a quasi-experimental research with a pretest-posttest control group design at the Obstetrics and Gynecology Clinic of Tokat Gaziosmanpaşa University Research and Practice Hospital, aiming to evaluate the effects of mindfulness-based postpartum discharge education on mothers' maternal role perception and anxiety levels. The sample will consist of 84 postpartum women (42 in the experimental group and 42 in the control group) who meet the inclusion criteria, determined through G*Power analysis. Stratified randomization will be used for group allocation. Data will be collected using a Personal Information Form, the Maternal Role Perception Scale, and the Postpartum Specific Anxiety Scale. Within the first 24 hours postpartum (baseline/pretest), the experimental group will receive a 60-minute individual "Mindfulness-Based Postpartum Education Program" administered by the researcher in addition to routine discharge care, while the control group will receive only standard hospital discharge education. One week after the education, a second measurement will be applied to both groups. Subsequently, the experimental group will be systematically followed up for one month via WhatsApp with weekly reminder messages and monitoring charts. At the end of the first postpartum month (30th day), the final posttest measurements will be completed. The effects of the education over repeated time points will be analyzed using SPSS 22.0 software with descriptive statistics, parametric tests (Independent/Paired Sample t-test, repeated measures Two-Way ANOVA, Pearson correlation), and non-parametric tests (Mann Whitney U, Wilcoxon, Spearman correlation) at a significance level of 0.05.

Study Overview

Status

Recruiting

Study Type

Observational

Enrollment (Estimated)

84

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Locations

    • Tokat Province
      • Tokat Province, Tokat Province, Turkey (Türkiye), 60100
        • Recruiting
        • Tokat Gaziosmanpasa University University Hospital
        • Contact:
        • Principal Investigator:
          • Damlagul ACAR, MSc Student

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult
  • Older Adult

Accepts Healthy Volunteers

Yes

Sampling Method

Non-Probability Sample

Study Population

Postpartum women aged 18 and older who had a healthy singleton birth and are hospitalized in the Obstetrics and Gynecology Clinic of Tokat Gaziosmanpasa University Research and Practice Hospital within their first 24 hours postpartum.

Description

Inclusion Criteria:

  • Mothers aged 18 and older who voluntarily agree to participate in the study
  • Mothers who have had a healthy singleton birth
  • Mothers who are in the postpartum ward within the first 24 hours after delivery
  • Mothers living in the same home environment with their baby
  • Mothers who can read and understand Turkish and fully complete the questionnaires
  • Mothers who can use mobile communication tools (e.g., WhatsApp)
  • Mothers whose health status is suitable to participate in the education process

Exclusion Criteria:

  • Mothers with serious physical or psychiatric illnesses in the postpartum period
  • Mothers whose newborns are admitted to the intensive care unit or have serious health problems
  • Mothers who have previously participated in a mindfulness-based education or therapy program
  • Mothers who cannot participate regularly in the education process or maintain communication during the follow-up period
  • Mothers who incompletely fill out the questionnaires or do not participate in the post-test phase

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

Cohorts and Interventions

Group / Cohort
Experimental Group
Mothers in this group will receive a mindfulness-based discharge education program.
Control Group
Mothers in this group will receive standard routine hospital discharge care.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Maternal Role Perception
Time Frame: Within the first 24 hours postpartum (baseline), at 1 week postpartum, and at 1 month postpartum.
Evaluated using the Maternal Role Perception Scale developed by Arpaci Kizildag and Yigit (2022). The scale consists of 26 items scored on a 5-point Likert-type scale (1=Strongly Disagree to 5=Strongly Agree) and includes reversed items. The total score ranges from 26 to 130. A total score of 26 indicates the lowest (worst) level of maternal role perception, while a total score of 130 indicates the highest (best) and most advanced level of maternal role perception. Higher scores signify a better and more developed perception of the maternal role.
Within the first 24 hours postpartum (baseline), at 1 week postpartum, and at 1 month postpartum.

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Postpartum Specific Anxiety Scale
Time Frame: Within the first 24 hours postpartum (baseline), at 1 week postpartum, and at 1 month postpartum.
Evaluated using the Postpartum Specific Anxiety Scale - Turkish Version (PSAS-TR) adapted by Duran (2019). The scale consists of 47 items scored on a 4-point Likert-type scale (1=Never to 4=Almost always). The total score ranges from 47 to 188. Higher scores signify a higher level of postpartum anxiety. Specifically, a total score of 73 or below indicates low anxiety, a score between 74 and 100 indicates moderate anxiety, and a score of 101 or above indicates a high level of postpartum anxiety.
Within the first 24 hours postpartum (baseline), at 1 week postpartum, and at 1 month postpartum.

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

July 9, 2026

Primary Completion (Estimated)

September 9, 2026

Study Completion (Estimated)

December 31, 2026

Study Registration Dates

First Submitted

July 9, 2026

First Submitted That Met QC Criteria

July 9, 2026

First Posted (Actual)

July 14, 2026

Study Record Updates

Last Update Posted (Actual)

July 14, 2026

Last Update Submitted That Met QC Criteria

July 9, 2026

Last Verified

July 1, 2026

More Information

Terms related to this study

Additional Relevant MeSH Terms

Other Study ID Numbers

  • 718430

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Anxiety

Subscribe